About Priyanka Mandal
Priyanka is a passionate investment analyst and commentator. After earning a master's degree in economics, her interest in financial markets motivated her to begin her career in investment research.
Her approach is to find a financial instruments’ intrinsic value for predicting its future price movement.
Recent Articles By Priyanka Mandal
Take Advantage of the Market Sell-Off and Buy These 3 Beaten-Down Growth Stocks
Because the stock market is volatile due to rising inflationary pressure and the Fed's decision to hike interest rates, it could be wise to bet on quality growth stocks that are available at lower price levels to reap maximum rewards over the long run. Beaten-down stocks Intel (INTC), Intuit (INTU), and NetEase (NTES) possess solid growth attributes. So, we think it could be worth adding them to one’s portfolio now.
4 Overvalued Cannabis Stocks Investors Should Continue to Avoid
The cannabis industry witnessed solid growth last year on a legalization wave and increasing demand for innovative cannabis products. But while the industry is expected to maintain its momentum this year, some cannabis stocks are trading at lofty valuations despite their companies’ relatively weak growth prospects. So, we think overvalued cannabis stocks Canopy Growth (CGC), Cresco (CRLBF), Aurora Cannabis (ACB), and Sundial (SNDL) are best avoided now. Read on.
3 Top Dow Jones Stocks to Safeguard Your Portfolio
The market remains turbulent amid worries related to rising inflation, looming interest rate hikes, and geopolitical tensions. However, the Dow Jones Industrial Average is down the least out of the three major indices. Investing in hot Dow stock Merck (MRK), Amgen (AMGN), and Walgreens (WBA) could help safeguard your portfolio returns. These stocks also offer a steady income stream through dividend payments.
4 Consumer Defensive Stocks Bucking the Market's Downward Trend
The Fed’s decision to raise interest rates, a disappointing employment report, rising inflation, and persistent supply chain disruptions will likely continue spooking investors. So, in this environment, we think consumer defensive stocks Coca-Cola (KO), Colgate (CL), General Mills (GIS), and Hershey (HSY), which typically perform with aplomb during periods of market disquiet due to the relatively inelastic demand for their products, could be great picks now. Read on.
Even After the Recent Sell-Off, Stay Away from These 3 Overvalued Electric Vehicle Stocks
The electric vehicle (EV) industry is expected to witness a surge in sales this year due to improved battery technology, advanced features, affordable prices, and more charging stations. While these factors should benefit most EV stocks, the shares of a few are trading at lofty valuations despite their companies’ relatively weak growth prospects. Here are three examples: We think Lucid Group (LCID), Fisker (FSR), and Nikola (NKLA) look significantly overvalued at their current price levels, even after suffering a sell-off lately. So, these stocks are best avoided now. Let’s discuss.
2 Dow Jones Stocks That Rallied Last Week as the Market Tanked
The major stock market indices tanked last week, marking their worst week since the onset of the COVID-19 pandemic. However, escaping the broader market sell-off, Dow Jones stocks Procter & Gamble (PG) and Chevron (CVX) rallied on their solid growth prospects. So, let's take a closer look at these names.
Now could be a Good Time to Scoop Up These 4 Fintech Stocks Wall Street Predicts Have 120% to 170% Upside
With digitization continuing globally, the fintech industry has achieved significant growth over the past couple of years. In addition, fintech companies’ rising investments in technological innovations to deliver better customer experiences should also help the industry thrive. Therefore, Wall Street analysts expect fintech stocks Block (SQ), Affirm Holdings (AFRM), Robinhood Markets (HOOD), and Upstart (UPST) to deliver substantial returns in the coming months. Let’s discuss.
3 Oversold Medical Equipment and Device Stocks to Scoop Up Right Now
A growing demand for early medical diagnosis is driving the market for advanced medical equipment by healthcare centers and hospitals. Also, increasing spending on research & development by medical technology companies to deliver innovative technology is helping the industry rebound. So, we think the recent price dips in the stocks of medical device companies IDEXX (IDXX), Align Technology (ALGN), and West Pharmaceutical (WST) offer a good entry opportunity. Let’s discuss.
3 Semiconductor Stocks to Buy as the Supply Crunch Gets Worse
With the emergence of the COVID-19 omicron variant in China, global supply chain issues continue to worsen. However, famous semiconductor chip makers are ramping up production and building facilities to satisfy the huge demand for semiconductors. With the worsening supply crunch driving prices higher, we think fundamentally sound semiconductor stocks Taiwan Semiconductor (TSM), Intel (INTC), and Kulicke and Soffa (KLIC) could be great bets now. Read on.